Optimum Perspectives
Claim This Podcastby Optimum Strategic Communications
Podcast Authority
Beta
Podcast Overview
<p><a href="https://www.optimumcomms.com/podcast/" rel="noopener noreferrer" target="_blank">Optimum Insights: Interviews with industry leaders of the healthcare sector in regular episodes highlighting the latest innovation and developments in life sciences.</a></p><p>Follow us on <a href="https://www.linkedin.com/company/optimum-strategic-communications/" rel="noopener noreferrer" target="_blank">Linkedin</a> and <a href="https://twitter.com/OptimumComms" rel="noopener noreferrer" target="_blank">Twitter</a> for news and highlights on the life sciences industry. Reach out via our contact page on our website: <a href="https://www.optimumcomms.com/" rel="noopener noreferrer" target="_blank">www.optimumcomms.com</a></p><hr><p style='color:grey; font-size:0.75em;'> Hosted on Acast. See <a style='color:grey;' target='_blank' rel='noopener noreferrer' href='https://acast.com/privacy'>acast.com/privacy</a> for more information.</p>
Language
🇺🇲
Publishing Since
1/23/2023
Unlock The Full Podcast Authority Score Report
See how your podcast performs across key metrics
Podcast Authority
BetaRecommendations available
Unlock the full report to see detailed tips
Recommendations available
Unlock the full report to see detailed tips
Unlock comprehensive insights including:
- • YouTube presence analysis
- • Social media reach metrics
- • RSS compliance scoring
- • Podcast 2.0 features
- • Technical standards
Detailed Analytics
- Complete breakdown of all 19 authority metrics
- Personalized recommendations for each metric
- Industry benchmarks and comparisons
- Technical RSS feed analysis and compliance scoring
Growth Strategies
- Step-by-step action plans for improvement
- Quick wins to boost your score immediately
- Pro tips from successful podcasters
See how your show performs across every key metric
High authority scores make your podcast more attractive to industry leaders and influencers who want to appear on credible shows.
Sponsors look for podcasts with proven authority and engagement. Your score demonstrates your podcast's value to potential partners.
Understanding your strengths and weaknesses helps you make data-driven decisions to expand your listener base effectively.
2 verified contact emails on file for Optimum Perspectives
Pitch yourself as a guest, propose sponsorships, or reach out directly to the host.
Recent Episodes
June 19, 2026
New approaches to treating kidney disease
Dialysis and transplantation have transformed the lives of people with serious kidney disease. But that does not mean it is “job done”. Individuals who need dialysis have significantly reduced life expectancy, especially if they must remain on it for a long time, while there is a shortage of donor kidneys – and transplantation carries its own problems. In this latest Optimum Perspectives podcast, three experts who are all developing new treatments for various aspects of kidney disease, share their thoughts. Stephen Adams hosts the episode, which features Renée Aguiar-Lucander, CEO of Hansa Biopharma; Krishna Polu, CEO of R1 Therapeutics; and Thomas Kledal, CEO of Synklino.<hr><p style='color:grey; font-size:0.75em;'> Hosted on Acast. See <a style='color:grey;' target='_blank' rel='noopener noreferrer' href='https://acast.com/privacy'>acast.com/privacy</a> for more information.</p>
March 13, 2026
How sleep architecture shapes brain health: new frontiers in Alzheimer’s research
<p>On World Sleep Day 2026, Optimum is marking the occasion with a brand-new podcast episode featuring Magnus Ivarsson, CSO of AstronauTx and Prof. Liz Coulthard from the University of Bristol.</p><p> </p><p>Did you know getting enough high quality sleep could help protect against developing neurological diseases including Alzheimer’s? This episode delves into the groundbreaking research our guests are doing in the intersection between sleep and neurodegeneration. </p><hr><p style='color:grey; font-size:0.75em;'> Hosted on Acast. See <a style='color:grey;' target='_blank' rel='noopener noreferrer' href='https://acast.com/privacy'>acast.com/privacy</a> for more information.</p>
February 26, 2026
Closing the gap on rare diseases in 2026
<p>Ahead of Rare Disease Day 2026, Optimum is marking the occasion with a brand-new podcast episode featuring Hans Schambye, CEO of BOOST Pharma, Jean-Marie Cuillerot, CMO of Kainova Therapeutics, and Josep Prous, Co‑founder & CSO of CONNECTA.</p><br><p>This episode delves into the critical gaps in therapeutic options for the more than 300 million people living with rare diseases worldwide and explores why this field is rapidly gaining attention from both researchers and investors.</p><br><p>Our guests also share insights into their life‑changing work across brittle bone disease, oncology, and fragile X syndrome, highlighting the breakthroughs that are bringing new hope to patients and families.</p><hr><p style='color:grey; font-size:0.75em;'> Hosted on Acast. See <a style='color:grey;' target='_blank' rel='noopener noreferrer' href='https://acast.com/privacy'>acast.com/privacy</a> for more information.</p>
40 total episodes available
Deep-dive analytics for Optimum Perspectives
Frequently asked questions
Have a different question and can't find the answer you're looking for? Reach out to our support team by sending us an email and we'll get back to you as soon as we can.
- What is Optimum Perspectives?
<p><a href="https://www.optimumcomms.com/podcast/" rel="noopener noreferrer" target="_blank">Optimum Insights: Interviews with industry leaders of the healthcare sector in regular episodes highlighting the latest innovation and developments in life sciences.</a></p><p>Follow us on <a href="https://www.linkedin.com/company/optimum-strategic-communications/" rel="noopener noreferrer" target="_blank">Linkedin</a> and <a href="https://twitter.com/OptimumComms" rel="noopener noreferrer" target="_blank">Twitter</a> for news and highlights on the life sciences industry. Reach out via our contact page on our website: <a href="https://www.optimumcomms.com/" rel="noopener noreferrer" target="_blank">www.optimumcomms.com</a></p><hr><p style='color:grey; font-size:0.75em;'> Hosted on Acast. See <a style='color:grey;' target='_blank' rel='noopener noreferrer' href='https://acast.com/privacy'>acast.com/privacy</a> for more information.</p> - How often does this podcast release new episodes?
This podcast updates bi-weekly.
- Where can I listen to this podcast?
This podcast is available on 9 platforms including Apple Podcasts, Spotify, and more. You can also use the RSS feed directly.
- Does this podcast accept guests?
No, this podcast does not typically feature guests.
Legal Disclaimer
Pod Engine is not affiliated with, endorsed by, or officially connected with any of the podcasts displayed on this platform. We operate independently as a podcast discovery and analytics service.
All podcast artwork, thumbnails, and content displayed on this page are the property of their respective owners and are protected by applicable copyright laws. This includes, but is not limited to, podcast cover art, episode artwork, show descriptions, episode titles, transcripts, audio snippets, and any other content originating from the podcast creators or their licensors.
We display this content under fair use principles and/or implied license for the purpose of podcast discovery, information, and commentary. We make no claim of ownership over any podcast content, artwork, or related materials shown on this platform. All trademarks, service marks, and trade names are the property of their respective owners.
While we strive to ensure all content usage is properly authorized, if you are a rights holder and believe your content is being used inappropriately or without proper authorization, please contact us immediately at hey@podengine.ai for prompt review and appropriate action, which may include content removal or proper attribution.
By accessing and using this platform, you acknowledge and agree to respect all applicable copyright laws and intellectual property rights of content owners. Any unauthorized reproduction, distribution, or commercial use of the content displayed on this platform is strictly prohibited.